Sectoral Asset Management Inc

13F Holdings History for Contineum Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (CTNM)

Symbol: CTNM on Nasdaq
Investment type: Equity / Class A Common Stock, $0.001 par value per share
Latest Disclosed Ownership: 951K shares
Security Ownership: 4.99%

Shares, Excluding Options vs Price

Value, Excluding Options

Jerome G. Pfund ownership in Contineum Therapeutics, Inc. Class A Common Stock, $0.001 par value per share (CTNM)

2025-02-14 - Jerome G. Pfund has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 951K shares of Contineum Therapeutics, Inc. Class A Common Stock, $0.001 par value per share (CTNM). This represents 4.99% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Jerome G. Pfund	4.99%		$6.14M	951K			$6.46	13G/A	12/31/2024	14 Feb 2025 10:50:26

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	5.81%		$9.41M	801K			$11.75	Q3 2025
6/30/2025	2.1%		$3.18M	801K			$3.97	Q2 2025
3/31/2025	4.35%		$5.59M	801K			$6.98	Q1 2025
12/31/2024	7.83%	0%	$11.7M	801K	-100	-0.01%	$14.65	Q4 2024
9/30/2024	9.19%		$15.3M	801K			$19.14	Q3 2024
6/30/2024	5.73%	+5.59%	$14.1M	801K	+800,887	NEW	$17.61	Q2 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.